Articles Vol. 67 No. CĐ5-NCKH 04/05/2026

A RARE CASE OF DUODENAL ECTROPIC CANCER

Nguyen Viet Thu1,2, Hoang Van Lan Duc1,2, Ngo Van Doan1,2, Vu Huy Hoang1,2, Nguyen Truong Duc1,2
1 Center for Diagnostic Imaging and Interventional Radiology, Vinmec Times City International General Hospital
2 Trung tâm Chẩn đoán hình ảnh và Điện quang can thiệp, Bệnh viện Đa khoa Quốc tế Vinmec Times City
DOI: 10.52163/yhc.v67iCD5.4968
22 Views
10 Downloads
Abstract

Duodenal adenocarcinoma is a rare malignancy of the gastrointestinal tract, often diagnosed at a late stage due to nonspecific symptoms. While complete surgical resection offers the best long-term survival rate, recurrence rates remain significant, with the majority of recurrences occurring within the first two years. However, specific guidelines for optimal management of recurrence after surgery for duodenal adenocarcinoma are still lacking. Treatment guidelines are based on a small number of cases or on colorectal cancer treatment protocols, posing a significant challenge for clinicians in improving patient outcomes.

This case report highlights a rare case of duodenal adenocarcinoma that underwent pancreaticoduodenectomy, lymph node dissection, and abdominal lymph node recurrence, aiming to describe a treatment strategy and contribute to the limited body of evidence for this rare and challenging condition.

References
[1]
Alwmark A, Andersson A et al. Primary carcinoma of the duodenum. Ann Surg, 1980, 191 (1): 13-18. doi: 10.1097/00000658-198001000-00003. Google Scholar
[2]
Jang B.S, Park H.J et al. Role of adjuvant chemoradiotherapy for duodenal cancer: an updated analysis of long-term follow-up from single institution. World J Surg, 2018, 42 (10): 3294-3301. Google Scholar
[3]
Hatzaras I, Palesty J.A et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut tumor registry. Arch Surg, 2007, 142 (3): 229-235. doi: 10.1001/archsurg.142.3.229. Google Scholar
[4]
Ho Xuan Tuan, Dau Quang Lieu và cộng sự. A rare case of duodenal adenocarcinoma. Radiol Case Rep, 2023, 18 (12): 4400-4403. Google Scholar
[5]
Sun H, Liu Y et al. Prognostic factors and clinical characteristics of duodenal adenocarcinoma with survival: a retrospective study. Front Oncol, 2021, 11: 795891. doi: 10.3389/fonc.2021.795891. Google Scholar
[6]
Kalogerinis P.T, Poulos J.E et al. Duodenal carcinoma at the ligament of Treitz: a molecular and clinical perspective. BMC Gastroenterol, 2010, 10: 109. doi: 10.1186/1471-230X-10-109. Google Scholar
[7]
Kim M.J et al. Clinicopathological characteristics and survival of duodenal adenocarcinoma. J Korean Surg Soc, 2013, 84 (2): 83-89. Google Scholar
[8]
Czaykowski P, Hui D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin Oncol (R Coll Radiol), 2007, 19 (2): 143-9. Google Scholar
[9]
Han S.L, Cheng J et al. Surgically treated primary malignant tumor of small bowel: a clinical analysis. World J Gastroenterol, 2010, 16 (12): 1527-1532. Google Scholar